Cannabinoid-Immunophilin Signaling During Pregnancy
怀孕期间的大麻素-免疫亲和素信号传导
基本信息
- 批准号:7151732
- 负责人:
- 金额:$ 3.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-02-01 至 2007-10-08
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The objective of the proposed research is to explore endocannabinoid-immunophilin signaling during embryo implantation using mice as an animal model. Cannabinoids exert a broad array of effects, including fertilization, embryo development, and implantation. Our lab has shown that uterine anandamide levels are tightly regulated during implantation, with lower levels conducive and higher levels detrimental. Functions of ovarian estrogen and progesterone are essential to implantation and pregnancy establishment and executed primarily via their cognitive nuclear receptors. FKBP52, an immunophilin, functions as a co-chaperone for nuclear steroid receptors and is required for their normal functioning. Female Fkbp52 null mice are infertile because of implantation failure resulting from compromised progesterone receptor function. Using multiple approaches, we will explore whether endocannabinoid signaling collaborates with that of immunophilin in rendering the uterus receptive for implantation with the eventual goal of determining whether the anandamide index serves as a marker of uterine receptivity. Widespread marijuana use and its known adverse effects on reproduction classifies this research as highly relevant to women's health issues.
描述(由申请人提供):拟议研究的目的是使用小鼠作为动物模型来探索胚胎植入过程中的内源性大麻素-免疫亲和素信号传导。大麻素具有广泛的作用,包括受精、胚胎发育和植入。我们的实验室表明,子宫 anandamide 水平在着床过程中受到严格调节,较低水平有利,较高水平有害。卵巢雌激素和孕激素的功能对于着床和妊娠的建立至关重要,并且主要通过其认知核受体来执行。 FKBP52 是一种亲免素,作为核类固醇受体的共伴侣,是其正常功能所必需的。雌性 Fkbp52 缺失小鼠因黄体酮受体功能受损导致着床失败而无法生育。我们将使用多种方法探索内源性大麻素信号传导是否与亲免素信号传导协同作用使子宫接受植入,最终目标是确定 anandamide 指数是否可以作为子宫接受性的标志。大麻的广泛使用及其已知的对生殖的不利影响使这项研究与女性健康问题高度相关。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSANNE L TRANGUCH其他文献
SUSANNE L TRANGUCH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Quorum Sensing Regulation of EHEC Virulence Genes
肠出血性大肠杆菌毒力基因的群体感应调控
- 批准号:
10384063 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis
暴露于大麻的 HIV Tat 转基因小鼠食欲学习过程中的体内钙成像
- 批准号:
10696442 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
Activity-dependent endocannabinoid control in epilepsy
癫痫的活动依赖性内源性大麻素控制
- 批准号:
10639147 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
Uncovering sleep and circadian mechanisms contributing to adverse metabolic health
揭示导致不良代谢健康的睡眠和昼夜节律机制
- 批准号:
10714191 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
Developing multitarget enzyme inhibitors as safe and effective anti-migraine treatments
开发多靶点酶抑制剂作为安全有效的抗偏头痛治疗方法
- 批准号:
10714658 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
Indiana University Bloomington (IUB) Center for Cannabis, Cannabinoids, and Addiction (C3A)
印第安纳大学伯明顿分校 (IUB) 大麻、大麻素和成瘾中心 (C3A)
- 批准号:
10713089 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
The lipid hydrolase NAAA as a target for non-addictive analgesic medications
脂质水解酶 NAAA 作为非成瘾性镇痛药物的靶标
- 批准号:
10584428 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
2023 Cannabinoid Function in the CNS Gordon Research Conference and Gordon Research Seminar
2023中枢神经系统戈登研究会议和戈登研究研讨会大麻素功能
- 批准号:
10683605 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial
大麻二酚对有阿尔茨海默病风险的个体来说:一项随机安慰剂对照试验
- 批准号:
10677333 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别:
Exercise facilitation of adolescent fear extinction, frontolimbic circuitry, and endocannabinoids
运动促进青少年恐惧消退、额边缘回路和内源性大麻素
- 批准号:
10648773 - 财政年份:2023
- 资助金额:
$ 3.14万 - 项目类别: